Critical review of antipsychotic polypharmacy in the treatment of schizophrenia

Antipsychotic polypharmacy remains prevalent; it has probably increased for the treatment of schizophrenia in real-world clinical settings. The current evidence suggests some clinical benefits of antipsychotic polypharmacy, such as better symptom control with clozapine plus another antipsychotic, an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The International Journal of Neuropsychopharmacology 2014-07, Vol.17 (7), p.1083-1093
Hauptverfasser:	Fleischhacker, W. Wolfgang, Uchida, Hiroyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Aripiprazole Clinical Trials as Topic Clozapine - adverse effects Clozapine - therapeutic use Humans Piperazines - adverse effects Piperazines - therapeutic use Polypharmacy Practice Patterns, Physicians Quinolones - adverse effects Quinolones - therapeutic use Reviews Schizophrenia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!